Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

FLKS

FLEX PHARMA, INC. (FLKS)

Flex Pharma, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FLKS
FechaHoraFuenteTítuloSímboloCompañía
12/11/201915:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLKSFlex Pharma, Inc.
28/10/201907:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FLKSFlex Pharma, Inc.
28/10/201907:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
18/09/201916:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FLKSFlex Pharma, Inc.
18/09/201915:56Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:FLKSFlex Pharma, Inc.
13/09/201917:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FLKSFlex Pharma, Inc.
13/09/201917:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:FLKSFlex Pharma, Inc.
13/09/201905:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLKSFlex Pharma, Inc.
29/07/201916:28Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FLKSFlex Pharma, Inc.
23/07/201918:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
18/07/201916:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLKSFlex Pharma, Inc.
12/07/201915:05Business WireFlex Pharma Announces Approval of all Merger-Related Proposals at Special MeetingNASDAQ:FLKSFlex Pharma, Inc.
27/06/201905:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FLKSFlex Pharma, Inc.
25/06/201906:00Business WireFlex Pharma Announces Broker Authority to Vote on Certain ProposalsNASDAQ:FLKSFlex Pharma, Inc.
20/05/201905:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FLKSFlex Pharma, Inc.
01/05/201906:00Business WireFlex Pharma Reports First Quarter 2019 Financial ResultsNASDAQ:FLKSFlex Pharma, Inc.
29/04/201914:23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:FLKSFlex Pharma, Inc.
24/04/201915:16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FLKSFlex Pharma, Inc.
18/04/201905:01Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:FLKSFlex Pharma, Inc.
16/04/201915:13Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FLKSFlex Pharma, Inc.
06/03/201916:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FLKSFlex Pharma, Inc.
06/03/201915:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FLKSFlex Pharma, Inc.
06/03/201906:00Business WireFlex Pharma Reports Fourth Quarter and Fiscal 2018 Financial ResultsNASDAQ:FLKSFlex Pharma, Inc.
14/02/201905:22Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:FLKSFlex Pharma, Inc.
12/02/201914:50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FLKSFlex Pharma, Inc.
05/02/201909:05Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:FLKSFlex Pharma, Inc.
04/01/201906:00Business WireFlex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera...NASDAQ:FLKSFlex Pharma, Inc.
21/12/201816:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLKSFlex Pharma, Inc.
06/12/201802:30PR Newswire (US)Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical OfficerNASDAQ:FLKSFlex Pharma, Inc.
05/11/201806:00Business WireFlex Pharma Reports Third Quarter 2018 Financial ResultsNASDAQ:FLKSFlex Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:FLKS

Su Consulta Reciente